Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 17/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6863514 | 0.90 | ADORA2A (0.58) | ADORA2AATM | |
| SCHEMBL6869931 | 0.89 | ADORA2A (0.72) | ADORA2ALMNATSHR | |
| SCHEMBL6869682 | 0.88 | ADORA2A (0.62) | ADORA2A | |
| SCHEMBL6870601 | 0.87 | ADORA2A (0.65) | ADORA2ALMNAHTTNPSR1 | |
| SCHEMBL6869273 | 0.85 | ADORA2A (0.56) | ADORA2A | |
| SCHEMBL6870373 | 0.83 | ADORA2A (0.54) | ADORA2ATSHRATM | |
| SCHEMBL6869719 | 0.81 | ADORA2A (0.61) | ADORA2A | |
| SCHEMBL6863238 | 0.81 | ADORA2A (0.47) | ADORA2ALMNAATM | |
| SCHEMBL6871702 | 0.81 | ADORA2A (0.77) | ADORA2A | |
| SCHEMBL6868951 | 0.80 | ADORA2A (0.56) | ADORA2ALMNAATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1347974-B1 | AMINOTRIAZOLOPYRIDIINE DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS | HOFFMANN LA ROCHE (CH) | 2004-11-03 | — | — | EP | disclosed |
| US-6506772-B1 | Pharmaceutically active salts thereof with activity as adenosine receptor ligands are disclosed. These compounds are the adenosine receptor. | HOFFMANN-LA ROCHE INC. | 2003-01-14 | — | — | US | disclosed |